Warfarin is one of the most widely used oral anticoagulants and is administrated for a variety of indications like atrial fibrillation, mechanical prosthetic heart valves, deep vein thrombosis and primary or secondary prevention of arterial or venous thromboembolic events. It has very narrow therapeutic index and the excess use of it is associated with bleeding and in addition, inadequate anticoagulation can cause thromboembolic events. Because of its unique pharmacokinetic properties, achievement of desired result requires regular measurements of the international normalized ratio (INR) to ensure that the patient had received adequate medication dose with the least bleeding risk (
1).
The inappropriate use of warfarin results in the risk of bleeding and thrombosis. Warfarin-associated intracranial hemorrhage (
2), with 50% mortality rate is one of the most drastic adverse drug events (ADEs). Inadequate anticoagulation causes thromboembolic events and also thrombosis on mechanical valves. Association of patient’s warfarin therapy knowledge and their demographic background and therapeutic outcomes were also studied (
3-
5). A survey done of Hu et al. (
4) showed that higher warfarin knowledge scores were related to high family income and also high level of education and self-employment. Barcellona et al. (
6) studied the association of warfarin knowledge and anticoagulation control in 219 patients. This study showed a positive relation between acceptable TTR and high warfarin knowledge score. Another survey in Qatar showed a positive association between warfarin knowledge and INR control in patients with warfarin use (
5). In a survey by Davis et al. with an 18-question multiple-choice test, no positive relation between patients’ demographic characteristics, warfarin knowledge and anticoagulation control was seen (
7).